Psychedelic drugs: Follow the money as investors seek to replace Prozac, Zoloft and other drugs
Biotech startups and venture capital funds are investing in once-controversial treatments.
Source: advocate-news.com
📰 Empath Ventures News
Page 8 - Empath Ventures News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Empath Ventures. Real-time updates on events, politics, business and more.
Psychedelic drugs: Follow the money as investors seek to replace Prozac, Zoloft and other drugs
Biotech startups and venture capital funds are investing in once-controversial treatments.
Source: orovillemr.com
Psychedelic drugs: Follow the money as investors seek to replace Prozac, Zoloft and other drugs
Biotech startups and venture capital funds are investing in once-controversial treatments.
Source: greeleytribune.com
New psychedelic-like drugs: All treatment, no trip?
California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.
Source: morningjournal.com
Psychedelic drugs: Follow the money as investors seek to replace Prozac, Zoloft and other drugs
Biotech startups and venture capital funds are investing in once-controversial treatments.
Source: fortmorgantimes.com
Psychedelic drugs: Follow the biotech, venture capital money
Biotech startups and venture capital funds are investing in once-controversial treatments.
Source: mercurynews.com
New psychedelic-like drugs: All treatment, no 'trip'?
California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.
Source: mercurynews.com
Psychedelic drugs: Follow the biotech, venture capital money
Psychedelic drugs: Follow the money
Source: eastbaytimes.com
New psychedelic-like drugs: All treatment, no 'trip'?
California scientists race to concoct compounds that rewire the brain without euphoria or hallucinations.
Source: eastbaytimes.com
Rebroadcast: Psychedelics and who should be able to use them
In the '60s, some advocates wanted everyone to have access to psychedelics. Not everyone agreed. Now, with psychedelics growing in popularity, the tensions between access, money, and research are back.
Source: wbur.org